Related Experiment Video

Updated: Aug 11, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Eikenella corrodens infections in children

J G Raffensperger

    Journal of Pediatric Surgery
    |July 1, 1986
    PubMed

    Insights

    Recent advancements allow identification of rare bacteria like Eikenella corrodens in surgical infections. This organism, often found in oral contamination, requires surgical debridement and prolonged antibiotics for treatment.

    Area of Science:

    • Medical Microbiology
    • Infectious Diseases
    • Surgical Infections

    Background:

    • Improved bacteriologic specimen techniques enhance pathogen identification.
    • Rare fastidious organisms are increasingly detected in surgical infections.
    • Eikenella corrodens is an emerging pathogen in pediatric surgical cases.

    Purpose of the Study:

    • To report the incidence and clinical significance of Eikenella corrodens in pediatric surgical infections.
    • To highlight the association of Eikenella corrodens with specific types of surgical wounds.
    • To outline appropriate management strategies for Eikenella corrodens infections.

    Main Methods:

    • Retrospective analysis of pediatric surgical cases over a 5-year period.
    • Identification of Eikenella corrodens through bacteriologic culturing.
    • Clinical data review for patient demographics, infection sources, and treatment outcomes.

    Main Results:

    • Eikenella corrodens was identified in 28 pediatric patients over 5 years.
    • The organism was most frequently isolated from perforated appendices and orally contaminated wounds.
    • Eikenella corrodens was often part of polymicrobial infections but also found in pure culture.

    Conclusions:

    • Eikenella corrodens is an important pathogen in pediatric surgical site infections, particularly those involving oral contamination.
    • Effective management necessitates prompt surgical intervention, including debridement of necrotic tissue.
    • Extended antibiotic therapy guided by culture and sensitivity testing is crucial for successful treatment and prevention of recurrence.

    More Related Videos

    Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

    Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

    Published on: October 29, 2014

    Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

    Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

    Published on: February 17, 2023

    Related Concept Videos

    Endocarditis II: Clinical Features of Infective Endocarditis01:25

    Endocarditis II: Clinical Features of Infective Endocarditis

    Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
    Endocarditis IV: Nursing Management01:29

    Endocarditis IV: Nursing Management

    Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
    Urinary Tract Infection I: Introduction01:26

    Urinary Tract Infection I: Introduction

    Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
    Staphylococcal Skin Infections01:29

    Staphylococcal Skin Infections

    Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
    Diphtheria01:28

    Diphtheria

    Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
    Bacterial Gastroenteritis01:18

    Bacterial Gastroenteritis

    Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...